
Bioengineers shed light on dosing challenges for cancer immunotherapy
A team of Rice University bioengineers has developed a mathematical model that clarifies why interleukin-12 (IL-12)—a potent immune-boosting protein that holds promise for cancer treatment—loses effectiveness over time when used as an immunotherapeutic. The research […]